Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Net Margin (2022 - 2025)

Historic Net Margin for Dare Bioscience (DARE) over the last 7 years, with Q3 2025 value amounting to 162340.76%.

  • Dare Bioscience's Net Margin fell 1511120800.0% to 162340.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 30538.58%, marking a year-over-year increase of 317739900.0%. This contributed to the annual value of 41430.9% for FY2024, which is 403567300.0% down from last year.
  • As of Q3 2025, Dare Bioscience's Net Margin stood at 162340.76%, which was down 1511120800.0% from 18079.54% recorded in Q2 2025.
  • Dare Bioscience's 5-year Net Margin high stood at 18079.54% for Q2 2025, and its period low was 162340.76% during Q3 2025.
  • Over the past 4 years, Dare Bioscience's median Net Margin value was 6029.29% (recorded in 2023), while the average stood at 26490.18%.
  • Over the last 5 years, Dare Bioscience's Net Margin had its largest YoY gain of 508786600bps in 2025, and its largest YoY loss of -1511120800bps in 2025.
  • Over the past 4 years, Dare Bioscience's Net Margin (Quarter) stood at 3.84% in 2022, then plummeted by -7379bps to 279.75% in 2023, then surged by 3126bps to 8465.75% in 2024, then crashed by -2018bps to 162340.76% in 2025.
  • Its Net Margin was 162340.76% in Q3 2025, compared to 18079.54% in Q2 2025 and 17927.98% in Q1 2025.